Quoting Portable Alpha “Management have done a great job developing the pipeline.”
I let the half-year results speak for Peter Idiot:
From page 6 of the results:
EXPENSES:
Research and development expenses were $6,339 (2007: $4,656) reflect the development on partnered and other projects. UP 36%
Product development expenses were $6,022 (2007: $5,928), consistent with the advancement of our clinical programs, particularly HRV, LANI and RSV. UP 3%
REVENUE:
Research revenue of $4,210 (2007: $4,915) represents fee for services provided as a result of the AstraZeneca and Boehringer Ingelheim collaboration agreements; DOWN 15%
Milestone payments of $NIL (2007: $3,419); DOWN 100%
Portable Alpha, Peter Cook is the most useless CEO you can ever find – a PROVEN failure as the CEO of OEC and a total parasite at BTA. Peter Cook is doing such a great job developing the pipeline that research revenue is down 15% and the Milestone payment has dropped to ZERO despite R&D development expenses going up 36%. It is no wonder you are impressed with Peter Cook refusing a $100m settlement offer and then after spending $30m in legal fees sold it for $20m.
- Forums
- ASX - By Stock
- many articles surfacing on tamiflu resistance
Quoting Portable Alpha “Management have done a great job...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online